On August 11, 2025, Jeffrey Silber from BMO Capital set a price target of $22 for AMN Healthcare (NYSE:AMN). At the time, AMN's stock was priced at $16.71, suggesting a potential increase of about 31.66% to reach the target. AMN Healthcare is a leading provider of healthcare staffing and workforce solutions in the United States, competing with companies like Cross Country Healthcare and CHG Healthcare.
AMN Healthcare recently reported its second-quarter 2025 results, which exceeded expectations. The company achieved adjusted earnings per share (EPS) of 30 cents, surpassing the Zacks Consensus Estimate by 76.5%. However, this EPS represents a 69.4% decline from the previous year. Despite the decline, the earnings beat indicates some positive aspects in the company's financial performance.
The company's revenues for the quarter were $658.2 million, marking an 11.1% decrease year over year. Nevertheless, this figure still surpassed the Zacks Consensus Estimate by 0.9%. This revenue performance suggests that AMN Healthcare is managing to maintain a steady flow of income despite the challenges it faces in the current market environment.
AMN Healthcare is experiencing challenges with its margins. The gross margin fell to 29.8%, and the operating margin decreased to 6.4% in the second quarter. Additionally, the company reported a GAAP loss per share of $3.02, compared to an EPS of 42 cents in the same period last year. These margin pressures are a concern for investors, as highlighted by the nearly 7.3% drop in AMN's shares in pre-market trading.
Currently, AMN's stock price is $16.50, reflecting a decrease of 4.29% with a change of $0.74. The stock has fluctuated between a low of $16.45 and a high of $17.59 during the day. Over the past year, AMN has reached a high of $59.19 and a low of $14.87. The company's market capitalization is approximately $631.7 million, with a trading volume of 574,738 shares on the NYSE.
